文献速递先天性心脏病外科

Fontan单心室姑息术后远期结局:区域登记数据的系统评价与荟萃分析

Long-term Outcomes after Fontan Single Ventricle Palliation: A Systematic Review and Meta-Analysis of Regional Registry Data.
PubMed 文献 · Ann Thorac Surg · 2026-10-06

该研究系统检索并汇总6项登记研究、共7,854例Fontan患者,重建个体患者数据评估远期生存与失败率。10年、20年、30年累积生存率分别为93.6%、87.2%、80.2%;ECC与LT技术生存均显著优于AP技术(p<0.001)。

要点

  • Fontan术后30年累积生存率达80.2%,优于既往报告
  • ECC最常见(62.1%),ECC与LT生存均显著优于AP技术(p<0.001)
  • 30年免于Fontan失败率为70.2%,需终身专科随访

核心结论

  • Fontan姑息术后的远期生存优于既往报告,ECC和LT技术均优于AP技术,需终身专科监测。

研究设计与样本

  • 系统评价与荟萃分析,纳入6项登记研究、共7,854例Fontan患者,采用重建个体患者数据的荟萃分析评估生存与失败率,并按Fontan技术行亚组分析。

主要发现

  • Fontan完成时平均年龄5.8岁,平均随访年龄21.4岁,男性占58.7%。
  • ECC占62.1%,LT占23.1%,AP技术占14.8%,5.1%患者接受早期外科翻修。
  • 10年、20年、30年累积生存率分别为93.6%、87.2%、80.2%。
  • ECC与LT较AP技术生存显著改善(p<0.001)。
  • 10年、20年、30年免于Fontan失败率分别为76.6%、74.9%、70.2%。

临床怎么用

  • 可用于向单心室姑息术后患者及家属说明预期远期生存与失败风险。
  • 随访中关注Fontan失败,强调终身专科化监测的必要性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While several Fontan patient registries have been established, a systematic analysis of these collective data does not exist to provide insight into long-term outcomes. This meta-analysis aims to provide an updated assessment of published Fontan patient outcomes. METHODS: A systematic search identified registry studies reporting long-term outcomes following the Fontan procedure. A reconstructed individual patient data-based meta-analysis assessed survival and failure rates. Subgroup analyses evaluated outcomes across different Fontan techniques. RESULTS: Six registry studies, including 7,854 Fontan patients, were included. The mean age at Fontan completion was 5.8 years, with a mean follow-up age of 21.4 years. 58.7% of patients were male. An extracardiac conduit (ECC) was used in 62.1% of patients, a lateral tunnel (LT) in 23.1%, and the atriopulmonary (AP) technique in 14.8%. 5.1% of patients underwent early surgical revision. Cumulative survival rates were 93.6% at 10 years, 87.2% at 20 years, and 80.2% at 30 years. Upon comparison, both ECC and LT were associated with significantly improved survival compared to the AP technique (p<0.001). Finally, freedom-from-Fontan-failure rates at 10, 20, and 30 years of follow-up were 76.6%, 74.9%, and 70.2%, respectively. CONCLUSIONS: These data demonstrate that Fontan palliation yields better long-term survival than previously reported. ECCs are most common, and both ECC and LT techniques outperform the AP technique. These data provide important context for patient counseling regarding expected long-term outcomes after single-ventricle palliation and underscore the need for lifelong specialized surveillance in this population.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Zoupas I, Kim S, Dobrila J, et al. Long-term Outcomes after Fontan Single Ventricle Palliation: A Systematic Review and Meta-Analysis of Regional Registry Data. Ann Thorac Surg. 2026. PMID: 42838369. doi:10.1016/j.athoracsur.2026.09.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。